We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Revolutionary Hearing Device Remains Invisible

By HospiMedica International staff writers
Posted on 04 Sep 2013
An innovative prosthetic hearing restoration device for moderate to severe sensorineural hearing loss represents a breakthrough technology.

Unlike regular hearing aids, the Esteem fully implantable prosthetic hearing restoration device does not use a microphone or a speaker; instead, it uses the natural eardrum to detect sounds and sends a clear message to the brain, via the auditory nerve, by stimulating the cochlea with a prosthetic stimulator. More...
In clinical trials, the device averaged a statistically significant increase in gain above hearing aids for speech reception threshold (SRT) and word recognition scores (WRS).

The surgical procedure involves mastoid surgery in addition to an extended facial recess surgical approach to access the ossicular chain, which is disarticulated during the implant procedure. The tips of the sensor and driver extend into the middle ear and are connected to the incus and stapes, respectively. The sound processor is implanted behind the ear, under the scalp, connected with insulated wires to the sensor and driver. Once implanted, the device is completely invisible, and does not interfere with bathing, showering, swimming, or other normal physical activities.

For approximately eight weeks after surgery, patients will not be able to hear through the ear in which the Esteem is implanted, and also suffer some tenderness for several days afterwards. After healing, the surgical incision is nearly invisible, appearing as a thin line that is generally hidden by the patient’s hair. Once hearing is restored, the battery will hold for 4.5–9 years, depending on usage. The Esteem prosthetic hearing restoration device is a product of Envoy Medical (St. Paul, MN, USA), and has been approved by the US Food and Drug Administration (FDA).

“Once implanted, Esteem is invisible, not just to others, but the patient is also unaware of its presence in their body. Recipients can resume a normal life,” said Shelly Amann, President of Envoy Medical.

Related Links:

Envoy Medical



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.